VIJAYPD

Vijaypd Ceutical Limited

Listed company · ISIN INE0WL901019 · NSE SM · FV ₹10
Last price
₹78
-1.27%today
What this company does

Vijaypd Ceutical Limited is a listed company. It booked ₹0 cr of revenue in its latest half year (H2 FY26).

26out of 100
Equitytale Health Score
Fragile

Healthier than 26% of listed companies we score, on the 4 of 6 measures we could read for it. Each measure is ranked against the 2,387–2,932 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
50

At close. Not part of the score.

Profitability & returns10

How much profit it earns on the money it employs

Balance sheet21

How much it owes, and whether earnings cover the interest

Cash quality11

Whether reported profit actually arrives as cash

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency, valuation. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Some things to watch
Strengths
✓ Promoters hold 56%
✓ No promoter shares pledged
Watch-outs
! Currently loss-making
! Low 0.0% return on equity
! Carries high debt (D/E 1.1)

What if I invest in VIJAYPD?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest half year + price
₹78▼ -1.27%
latest close · 2026-11-04
52-wk low ₹5469 sessions so far52-wk high ₹100
How good is the business?
How much profit it earns from its money and its sales.
Return on equity0.0%Weak
WeakFairStrong ▸15%
Return on capital0.0%Weak
WeakFairStrong
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity1.11High
LowModerateHigh ▸1
Current ratio1.77Healthy
Tight ◂1HealthyAmple
More figures
Market cap
—
Book value
—
EPS
₹0.00
latest half year
Net debt
₹19 cr
owes more than its cash
Enterprise value
—
EBITDA
₹0 cr
annualised
EBIT
₹0 cr
annualised
Operating margin
—
Return on assets
0.0%
Earnings yield
—
P/S
—
Sales / share
—
Tax rate
—
Face value
₹0
Working capital
₹33 cr
Current assets
₹77 cr
Current liabilities
₹43 cr
Delivery %
84.4%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest half year; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-04.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
Too few reliable models — the filings don't support two independent estimates of value.

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · H2 FY26 (consolidated)
Revenue from Operations₹0 cr
Other Income₹0 cr
Total Income₹0 cr
Cost of Materials₹0 cr
Purchases of Stock-in-Trade₹0 cr
Employee Benefit Expense₹0 cr
Finance Costs₹0 cr
Other Expenses₹0 cr
Total Expenses₹0 cr
Profit before Tax₹0 cr
Tax Expense₹0 cr
Net Profit₹0 cr
Where the money goes

Not enough income-statement detail filed to break this down yet.

Balance sheet & cash flow · as of Mar 2026
High debt
Total assets
₹101 cr
Shareholder equity
₹33 cr
parent shareholders
Total debt
₹37 cr
Cash
₹18 cr
Who owns it · 2026-09-30
No pledge
Promoter
56.4%
FII / Foreign
—
DII / Domestic
1.1%
Retail / others
42.4%
Promoter stake down 21.9% over the last 4 quarters.
Smart-money activity
Bulk / block deals
BoughtYASH HITESH PATEL · NSE3.90 L @ ₹82.621 Oct 26
SoldYASH HITESH PATEL · NSE10,000 @ ₹85.1921 Oct 26
SoldSUNILKUMAR MANGILAL BACHHAWAT · NSE1.00 L @ ₹84.121 Oct 26
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 30 Sep 2026
See the official result
1
ADOPTION OF AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS
Backed by 100% of shareholders other than promotersneeded 50%
5.41 L votes for, 0 against
2
APPOINTMENT OF MR. NARENDRA NAGINDAS SHAH (DIN: 09634043) AS NON-EXECUTIVE DIRECTOR, LIABLE TO RETIRE BY ROTATION
Backed by 100% of shareholders other than promotersneeded 50%
5.41 L votes for, 0 against
3
REMUNERATION TO DIRECTORS EXCEEDING THE OVERALL MANAGERIAL REMUNERATION LIMIT AS PER THE PROVISIONS OF SECTION 197 OF THE COMPANIES ACT 2013
Backed by 100% of shareholders other than promotersneeded 75%
5.41 L votes for, 0 against
4
APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS WITH M/S. SIDDHARTH DRUGS PRIVATE LIMITED
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
54.10 L votes for, 0 against

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 11 named members
owning 56.4% between them · as of 2026-09-30
VASANTI DHIRENDRA SHAH16.47%
DINA MADHUKAR SHAH8.60%
BHAVIN DHIRENDRA SHAH8.38%
NARENDRA NAGINDAS SHAH8.14%
HEMANTI JITENDRA SHAH5.44%
SAMIT MADHUKAR SHAH4.52%
JIGAR NARENDRA SHAH2.48%
KUSUM JITENDRA SHAH1.20%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹19 cr raised in Sep 2025 by selling shares to the public

As of Mar 2026, the company says it has spent 56% of what it set aside, leaving ₹9 cr still to be spent.

Funding of capital expenditure requirements of our company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of new machineries in MIDC - Shrirampur, Ahmednagar, Maharashtra
21%
₹2 cr of ₹11 cr
Repayment/prepayment of all or certain of our borrowings availed of by our Company
100%
₹5 cr of ₹5 cr
General corporate purposes
100%
₹74.2 L of ₹74.2 L
Issue related Expenses
100%
₹3 cr of ₹3 cr

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.